In recent weeks, as companies have shared details on their earnings during the first three months of the year, this divide has become increasingly pronounced.
Some businesses — the drugmakers, the grocers, the tech giants — have been able to power ahead despite stay-at-home orders. Microsoft’s cloud services sales have skyrocketed, and Nintendo’s “Animal Crossing” game has been a quarantine hit. Eli Lilly () received approval from the US Food and Drug Administration for its new cancer treatment last week.
But a larger subset of companies have found themselves on the sidelines, cut off from their customers or facing little to no demand for their products.